Prognostic Impact of Cytogenetic Abnormalities in Adult Patients with Philadelphia-Chromosome (Ph)-Negative Acute Lymphoblastic Leukemia (ALL) Who Underwent Allogeneic Stem Cell Transplant (allo-SCT)

被引：0

作者：

Shimizu, Hiroaki ^{[1
,2
]}

Saitoh, Takayuki ^{[3
]}

Okamoto, Shinichiro ^{[4
]}

Kanda, Yoshinobu ^{[5
]}

Kanamori, Heiwa ^{[6
]}

Takahashi, Satoshi ^{[7
]}

Ohashi, Kazuteru ^{[8
]}

Usuki, Kensuke ^{[9
]}

Nakaseko, Chiaki ^{[10
]}

Onizuka, Makoto ^{[11
]}

Sakura, Toru ^{[12
]}

Goto, Moritaka ^{[13
]}

Yano, Shingo ^{[14
]}

Fujisawa, Shin ^{[15
]}

Watanabe, Reiko ^{[16
]}

Aotsuka, Nobuyuki ^{[17
]}

Taguchi, Jun ^{[18
]}

Tomita, Naoto ^{[19
]}

Wakita, Hisashi ^{[17
]}

Nannya, Yasuhito ^{[20
]}

机构：

[1] Gunma Univ Hosp, Ctr Oncol, Gunma, Japan

[2] Kanto Study Grp Cell Therapy, Tokyo, Japan

[3] Gunma Univ, Grad Sch Hlth Sci, Dept Lab Sci, Gunma, Japan

[4] Keio Univ, Sch Med, Dept Med, Div Hematol, Tokyo 160, Japan

[5] Jichi Med Univ, Saitama Med Ctr, Div Hematol, Saitama, Japan

[6] Kanagawa Canc Ctr, Dept Hematol, Yokohama, Kanagawa 2410815, Japan

[7] Univ Tokyo, Inst Med Sciece, Adv Clin Res Ctr, Div Mol Therapy, Tokyo, Japan

[8] Tokyo Metropolitan Komagome Hosp, Div Hematol, Tokyo, Japan

[9] NTT Med Ctr Tokyo, Dept Hematol, Tokyo, Japan

[10] Chiba Univ, Grad Sch Med, Dept Clin Cell Biol & Med, Chiba, Japan

[11] Tokai Univ, Sch Med, Dept Hematol & Oncol, Isehara, Kanagawa 25911, Japan

[12] Saiseikai Maebashi Hosp, Leukemia Res Ctr, Gunma, Japan

[13] Tokyo Med Univ Hosp, Div Hematol, Tokyo, Japan

[14] Jilkei Univ, Tokyo, Japan

[15] Yokohama City Univ, Med Ctr, Dept Hematol, Yokohama, Kanagawa 232, Japan

[16] Saitama Med Univ, Saitama Med Ctr, Dept Hematol, Kawagoe, Saitama, Japan

[17] Japanese Red Cross Narita Hosp, Dept Hematol & Oncol, Narita, Japan

[18] Shizuoka Red Cross Hosp, Hematol, Shizuoka, Japan

[19] Yokohama City Univ, Grad Sch Med, Dept Internal Med & Clin Immunol, Yokohama, Kanagawa 232, Japan

[20] Univ Tokyo, Hematol & Oncol, Tokyo, Japan

来源：

BLOOD | 2015年 / 126卷 / 23期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[31] Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia
Dhedin, Nathalie
Huynh, Anne
Maury, Sebastien
Tabrizi, Reza
Beldjord, Kheira
Asnafi, Vahid
Thomas, Xavier
Chevallier, Patrice
Nguyen, Stephanie
Coiteux, Valerie
Bourhis, Jean-Henri
Hichri, Yosr
Escoffre-Barbe, Martine
Reman, Oumedaly
Graux, Carlos
Chalandon, Yves
Blaise, Didier
Schanz, Urs
Lheritier, Veronique
Cahn, Jean-Yves
Dombret, Herve
Ifrah, Norbert
BLOOD, 2015, 125 (16) : 2486 - 2496
[32] Indications for allogeneic hematopoietic cell transplantation for adults with Philadelphia-chromosome negative acute lymphoblastic leukemia in first complete remission: all about MRD?
Ibrahim Aldoss
Vinod Pullarkat
Bone Marrow Transplantation, 2019, 54 : 3 - 5
[33] USE OF PALIFERMIN IN ALLOGENEIC STEM CELL TRANSPLANTATION (SCT) FOR PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
Anderson, J. E.
Gulbis, A. M.
Cool, R. M.
Westmoreland, M. D.
de Lima, M.
Giralt, S.
Hosing, C.
Popat, U.
Qazilbash, M. H.
Shpall, E.
Khouri, I. F.
Champlin, R.
Kebriaei, P.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 113 - 113
[34] Postremission treatment with autologous stem cell transplantation (auto-SCT) or allogeneic stem cell transplantation (allo-SCT) in adults with acute lymphoblastic leukemia (ALL).: A phase II clinical trial (HOVON 18 ALL).
Dekker, AW
van't Veer, MB
van der Holt, B
Huijgens, PC
Verdonck, LF
Sonneveld, P
Comelissen, JJ
Verhoef, GEG
Schouten, HC
Wijermans, PW
van der Lelie, J
Schaafsma, MR
Löwenberg, B
BLOOD, 2001, 98 (11) : 859A - 859A
[35] Additional Cytogenetic Abnormalities with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia on Allogeneic Stem Cell Transplantation in the Tyrosine Kinase Inhibitor Era
Akahoshi, Yu
Mizuta, Shuichi
Shimizu, Hiroaki
Uchida, Naoyuki
Fukuda, Takahiro
Kanamori, Heiwa
Onizuka, Makoto
Ozawa, Yukiyasu
Ohashi, Kazuteru
Ohta, Shuichi
Eto, Tetsuya
Tanaka, Junji
Atsuta, Yoshiko
Kako, Shinichi
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (10) : 2009 - 2016
[36] Philadelphia chromosome positive (Ph+) adult acute lymphoblastic leukemia (ALL): Clinical and cytogenetic characteristics, prognostic factors and treatment outcome.
Thomas, X
Thiebaut, A
Olteanu, N
Charrin, C
Archimbaud, E
Fiere, D
BLOOD, 1997, 90 (10) : 3793 - 3793
[37] PHILADELPHIA-CHROMOSOME (PH1)-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) IS RESISTANT TO EFFECTIVE THERAPY FOR PH1-NEGATIVE ALL
ARLIN, ZA
FELDMAN, EJ
AHMED, T
LIEBOWITZ, D
SHAPIRO, LR
WILMOT, PL
ACTA HAEMATOLOGICA, 1989, 81 (04) : 217 - 218
[38] Prognostic impact of Philadelphia chromosome in elderly acute lymphoblastic leukemia patients ineligible for hematopoietic stem cell transplantation
Byun, Ja Min
CANCER RESEARCH, 2017, 77
[39] Prognostic impact of persistent cytogenetic abnormalities at complete remission in adult patients with acute lymphoblastic leukemia
Short, Nicholas J.
Kantarjian, Hagop M.
Jabbour, Elias J.
O'Brien, Susan M.
Faderl, Stefan
Burger, Jan A.
Garris, Rebecca
Qiao, Wei
Huang, Xuelin
Jain, Nitin
Konopleva, Marina
Kadia, Tapan M.
Daver, Naval
Borthakur, Gautam
Cortes, Jorge E.
Ravandi, Farhad
AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (04) : 385 - 389
[40] Imatinib mesylate as treatment of molecular relapse of Philadelphia-chromosome positive acute lymphoblastic leukemia (Ph plus ALL) after stem cell transplantation
Wassmann, B
Scheuring, U
Pfeifer, H
Martin, H
Klein, SA
Binckebanck, A
Stadler, M
Hertenstein, B
Bomhäuser, M
Basara, N
Schwerdtfeger, R
Bunjes, D
Gschaidmeier, H
Hoelzer, D
Ottmann, OG
BONE MARROW TRANSPLANTATION, 2003, 31 : S171 - S172

← 1 2 3 4 5 →